Affiliation:
1. Research Division, Faculty of Medicine Siriraj Hospital, Mahidol University , Bangkok , Thailand
2. Biomedical Research Incubator Unit, Faculty of Medicine Siriraj Hospital, Mahidol University , Bangkok , Thailand
Abstract
Abstract
The use of blood products for different medical purposes has increased in recent years. To meet increasing demand, some blood centers allow volunteer donors with thalassemic trait, glucose-6-phosphate dehydrogenase deficiency (G6PD) trait, and sickle cell trait (SCT) to donate blood if their hemoglobin values fall within acceptable ranges and show no signs of hemolysis. Currently, there are no standard guidelines or policies regarding the use or management of blood products obtained from these donors. However, in recent years, there has been advanced research on eligible donors who have these underlying conditions. In this review, we summarize the current knowledge from in vitro and in vivo studies regarding donor characteristics, changes in physical and biochemical parameters in blood products during processing and storage, and posttransfusion efficacy of blood products. In addition, we discuss some unresolved issues concerning blood products from thalassemic trait, G6PD-deficiency trait, and SCT donors.
Funder
Faculty of Medicine Siriraj Hospital, Mahidol University
Publisher
Oxford University Press (OUP)
Subject
Biochemistry (medical),Clinical Biochemistry
Reference71 articles.
1. Indications for blood and blood product transfusion;Yaddanapudi;Indian J Anaesth,2014
2. Use of blood components in clinical practice;Shorthouse;Nurs Stand,2019
3. Overview of blood components and their preparation;Basu;Indian J Anaesth,2014
4. Thalassemia trait and G6PD deficiency in Thai blood donors;Kittisares;Transfus Apher Sci,2019
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献